ENDRA Life Sciences Inc. (NDRA) recently announced it is moving forward with the commercialization of its Thermo Acoustic Enhanced UltraSound (TAEUS) device in Europe. The TAEUS device is essentially a point of care ((POC)) or field diagnostic hybrid of an ultrasound and MRI that can monitor the progression of one of the largest unmet medical needs worldwide. Non-Alcoholic Steatohepatitis (NASH) or the early stage of the disease called Non-Alcoholic Fatty Liver Disease (NAFLD), affects over 1 billion people worldwide. In the wake of the COVID-19 pandemic, the one thing that we all learned about was